Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Lower SP Holdings

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Feb 11, 2022 8:21am

107 Views

Post# 34419434

RE:RE:Lower SP Holdings

I had at the most a neutral reaction at Soleus initial investment in THTX via the OO...Funds do take risks and getting in early in the game is very risky but these funds are high risk tolerant and they win some and lose some.....
However the fact that they have been accumulating wuite a lot according to the latest 14 G Filing is worthy of mention.......What are they relying on? Just on PR s issued by the Company?
or on something else?

scarlet1967 wrote:

It looks like Soleus is accumulating quite a bit.

https://fintel.io/so/us/thtx/soleus-capital-master-fund-l-p

SPCEO1 wrote: We just filed our ownership position with the SEC. Our holdings have dropped considerably from last year but I never placed any sell orders in TH. We had a client who had a 7 figure amount of shares in his account die a couple of years ago and when his estate settled last year, most of his heirs took the assets to their own money managers. They may still own the stock but Stewardship Partners no longer manages those assets so it is not in our totals any longer. We also lost some other accounts over the last year which accounts for the rest of the decline in our ownership.

We still own just under 4 million shares and are hoping this investment will finally start paying off for our clients (or paying off again might be a better way to put it).

Other money manager should be reporting their holdings soon so it will be interesting to see what shows up. AIGH reduced their holdings slightly in the fourth quarter but most other hodlers have yet to report.